GeNeuro SA (EPA:GNRO)
France · Delayed Price · Currency is EUR 0.0308
0.00 (0.00%)
At close: Jan 30, 2026
GeNeuro Market Cap
GeNeuro has a market cap or net worth of €911.56 thousand as of January 30, 2026. Its market cap has decreased by -78.31% in one year.
Market Cap
911.56K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.03
Market Cap Chart
Since April 15, 2016, GeNeuro's market cap has decreased from 147.82M to 911.56K, a decrease of -99.38%. That is a compound annual growth rate of -40.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 911.56K | -1.91% |
| Dec 31, 2025 | 929.32K | -59.85% |
| Dec 31, 2024 | 2.31M | -91.46% |
| Dec 29, 2023 | 27.10M | -27.36% |
| Dec 30, 2022 | 37.30M | -52.68% |
| Dec 31, 2021 | 78.83M | 37.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aelis Farma | 21.00M |
| Poxel | 17.95M |
| GenSight Biologics | 17.40M |
| NFL Biosciences | 16.25M |
| Oncodesign Precision Medicine Société anonyme | 10.18M |
| Plant Advanced Technologies | 8.75M |
| TME Pharma | 6.77M |
| Aton | 5.13M |